HERCULES, CA – February 7, 2012 – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostics products, today announced the launch of My eInserts™, a free Internet-based tool that will allow Bio-Rad’s quality control (QC) customers to customize and view their product inserts at any time.
Available in over 25 languages, My eInserts offers Bio-Rad’s QC customers the option to customize their QC product insert data by selecting only the analytes, units, instruments, and/or methods they need. Customized inserts can be saved and selections can be viewed, printed, or edited as needed. Once saved, customized selections are easily duplicated for a new control lot. My eInserts provides automatic email notifications offering customers the most current product data, including updates to control products.
“We want to improve our customers’ experience by offering them a quick way to access and customize their product insert data,” said Leo Kaabi, Bio-Rad Quality Systems Division Manager. “My eInserts is an innovative offering that will significantly reduce the time our customers will spend searching for data. And as a part of Bio-Rad’s ongoing green efforts, laboratory professionals will appreciate wasting less paper in the process.”
For more information, please call 1-800-2-BIORAD (1-800-224-6723) or visit www.myeinserts.com.
About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) has remained at the center of scientific discovery for more than 50 years, manufacturing and distributing a broad range of products for the life science research and clinical diagnostic markets. The company is renowned worldwide among hospitals, universities, major research institutions, as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. Founded in 1952, Bio-Rad is headquartered in Hercules, California, and serves more than 100,000 research and industry customers worldwide through its global network of operations. The company employs over 6,800 people globally and had revenues exceeding $1.9 billion in 2010. For more information, visit www.bio-rad.com.
This release contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements generally can be identified by the use of forward-looking terminology such as, "believe," “expect,” “may,” “will,” “intend,” “estimate,” “continue,” or similar expressions or the negative of those terms or expressions. Such statements involve risks and uncertainties, which could cause actual results to vary materially from those expressed in or indicated by the forward-looking statements. For further information regarding the Company’s risks and uncertainties, please refer to the “Risk Factors” in the Company’s public reports filed with the Securities and Exchange Commission, including the Company’s most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. The Company cautions you not to place undue reliance on forward-looking statements, which reflect an analysis only and speak only as of the date hereof. Bio-Rad Laboratories, Inc., disclaims any obligation to update these forward-looking statements.
For more information contact:
Trudy Gillions, Product Manager
Bio-Rad Laboratories, Inc.
949-598-1200
trudy_gillions@bio-rad.com